US Patent 8518430 Dry mouldable drug formulation
Patent 8518430 was granted and assigned to Novo Nordisk on August, 2013 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 31, 2011
0
Date of Patent
August 27, 2013
0
Patent Application Number
13285470
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8518430 Dry mouldable drug formulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.